Annual EBIT
-$343.89 M
-$101.72 M-42.01%
December 31, 2024
Summary
- As of March 12, 2025, DYN annual earnings before interest & taxes is -$343.89 million, with the most recent change of -$101.72 million (-42.01%) on December 31, 2024.
- During the last 3 years, DYN annual EBIT has fallen by -$193.86 million (-129.22%).
- DYN annual EBIT is now -7047.91% below its all-time high of -$4.81 million, reached on December 31, 2018.
Performance
DYN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$97.11 M
+$8.55 M+8.09%
December 31, 2024
Summary
- As of March 12, 2025, DYN quarterly earnings before interest & taxes is -$97.11 million, with the most recent change of +$8.55 million (+8.09%) on December 31, 2024.
- Over the past year, DYN quarterly EBIT has dropped by -$25.15 million (-34.94%).
- DYN quarterly EBIT is now -1697.30% below its all-time high of -$5.40 million, reached on December 31, 2019.
Performance
DYN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$343.89 M
-$29.42 M-9.36%
December 31, 2024
Summary
- As of March 12, 2025, DYN TTM earnings before interest & taxes is -$343.89 million, with the most recent change of -$29.42 million (-9.36%) on December 31, 2024.
- Over the past year, DYN TTM EBIT has dropped by -$72.81 million (-26.86%).
- DYN TTM EBIT is now -5757.37% below its all-time high of -$5.87 million, reached on September 30, 2019.
Performance
DYN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DYN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.0% | -34.9% | -26.9% |
| 3 y3 years | -129.2% | -45.5% | -76.7% |
| 5 y5 years | -2214.3% | -45.5% | -76.7% |
DYN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -129.2% | at low | -171.4% | +8.1% | -129.2% | at low |
| 5 y | 5-year | -2214.3% | at low | -1697.3% | +8.1% | -2950.3% | at low |
| alltime | all time | -7047.9% | at low | -1697.3% | +8.1% | -5757.4% | at low |
Dyne Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$343.89 M(+42.0%) | -$97.11 M(-8.1%) | -$343.89 M(+9.4%) |
| Sep 2024 | - | -$105.66 M(+46.8%) | -$314.47 M(+16.0%) |
| Jun 2024 | - | -$71.96 M(+4.1%) | -$271.08 M(+2.0%) |
| Mar 2024 | - | -$69.16 M(+2.2%) | -$265.85 M(+9.8%) |
| Dec 2023 | -$242.16 M(+41.6%) | -$67.69 M(+8.7%) | -$242.16 M(+12.8%) |
| Sep 2023 | - | -$62.27 M(-6.7%) | -$214.62 M(+10.3%) |
| Jun 2023 | - | -$66.74 M(+46.8%) | -$194.62 M(+7.7%) |
| Mar 2023 | - | -$45.46 M(+13.2%) | -$180.64 M(+5.7%) |
| Dec 2022 | -$170.96 M | -$40.15 M(-5.0%) | -$170.96 M(-6.5%) |
| Sep 2022 | - | -$42.28 M(-19.9%) | -$182.78 M(-0.3%) |
| Jun 2022 | - | -$52.76 M(+47.4%) | -$183.26 M(+14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$35.78 M(-31.1%) | -$160.67 M(+7.1%) |
| Dec 2021 | -$150.03 M(+154.1%) | -$51.96 M(+21.5%) | -$150.03 M(+18.5%) |
| Sep 2021 | - | -$42.77 M(+41.8%) | -$126.63 M(+29.7%) |
| Jun 2021 | - | -$30.16 M(+20.0%) | -$97.66 M(+27.9%) |
| Mar 2021 | - | -$25.13 M(-12.0%) | -$76.35 M(+29.3%) |
| Dec 2020 | -$59.04 M(+297.3%) | -$28.57 M(+107.2%) | -$59.04 M(+64.6%) |
| Sep 2020 | - | -$13.79 M(+55.7%) | -$35.88 M(+28.3%) |
| Jun 2020 | - | -$8.86 M(+13.1%) | -$27.96 M(+46.4%) |
| Mar 2020 | - | -$7.83 M(+44.9%) | -$19.10 M(+69.4%) |
| Dec 2019 | -$14.86 M(+208.9%) | -$5.40 M(-8.0%) | -$11.27 M(+92.0%) |
| Sep 2019 | - | -$5.87 M | -$5.87 M |
| Dec 2018 | -$4.81 M | - | - |
FAQ
- What is Dyne Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Dyne Therapeutics?
- What is Dyne Therapeutics annual EBIT year-on-year change?
- What is Dyne Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly EBIT year-on-year change?
- What is Dyne Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Dyne Therapeutics?
- What is Dyne Therapeutics TTM EBIT year-on-year change?
What is Dyne Therapeutics annual earnings before interest & taxes?
The current annual EBIT of DYN is -$343.89 M
What is the all time high annual EBIT for Dyne Therapeutics?
Dyne Therapeutics all-time high annual earnings before interest & taxes is -$4.81 M
What is Dyne Therapeutics annual EBIT year-on-year change?
Over the past year, DYN annual earnings before interest & taxes has changed by -$101.72 M (-42.01%)
What is Dyne Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of DYN is -$97.11 M
What is the all time high quarterly EBIT for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly earnings before interest & taxes is -$5.40 M
What is Dyne Therapeutics quarterly EBIT year-on-year change?
Over the past year, DYN quarterly earnings before interest & taxes has changed by -$25.15 M (-34.94%)
What is Dyne Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of DYN is -$343.89 M
What is the all time high TTM EBIT for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM earnings before interest & taxes is -$5.87 M
What is Dyne Therapeutics TTM EBIT year-on-year change?
Over the past year, DYN TTM earnings before interest & taxes has changed by -$72.81 M (-26.86%)